BMED
Price
$36.32Alerts
Change
-$0.12 (-0.33%)
Updated
Nov 13 closing price
Net Assets
14.56M
Intraday BUY SELL Signals
CRL
Price
$337.97Alerts
Change
-$2.84 (-0.83%)
Updated
Nov 13 closing price
Capitalization
16.11B
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMED vs CRL

BMED vs CRL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BMED vs. CRL commentary
Nov 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMED is a Hold and CRL is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BMED with price predictions
Nov 13, 2026

BMED sees MACD Histogram just turned negative

BMED saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 36 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BMED moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 24 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 66 cases where BMED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMED as a result. In 72 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

BMED broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 223 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 216 of 281 cases where BMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

A.I.Advisor
a Summary for CRL with price predictions
Nov 13, 2026

CRL sees its Stochastic Oscillator ascends from oversold territory

On November 09, 2026, the Stochastic Oscillator for CRL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In 44 of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +12.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in 200 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 145 of 228 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Bearish Trend Analysis

The 10-day RSI Indicator for CRL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 21 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRL as a result. In 62 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

The Moving Average Convergence Divergence Histogram (MACD) for CRL turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 40 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

CRL broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 1 (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.674) is normal, around the industry mean (67.298). P/E Ratio (-70.170) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.340) is also within normal values, averaging (9.775).

The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
1
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEDCRL
RSI
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement

BMED and

Correlation & Price change

A.I.dvisor tells us that BMED and CRL have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and CRL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMED
1D Price
Change %
BMED100%
-0.34%
CRL - BMED
16%
Poorly correlated
-0.83%
BDX - BMED
15%
Poorly correlated
+1.08%
MCRB - BMED
13%
Poorly correlated
-0.71%
GKOS - BMED
13%
Poorly correlated
-0.13%
VRTX - BMED
13%
Poorly correlated
-0.74%
More

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.83%
RGEN - CRL
56%
Loosely correlated
+0.76%
AZTA - CRL
56%
Loosely correlated
+4.08%
MEDP - CRL
56%
Loosely correlated
-0.44%
BRKR - CRL
53%
Loosely correlated
+2.09%
SHC - CRL
52%
Loosely correlated
+1.90%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GVAL36.360.24
+0.65%
Cambria Global Value ETF (GVAL)
MVRL7.930.05
+0.58%
ETRACS Monthly Pay 1.5x Leveraged Mortgage REIT ETN (MVRL)
SLYV106.150.18
+0.17%
State Street SPDR S&P 600 Small Cap Value ETF (SLYV)
ZAUG27.90-0.04
-0.14%
Innovator 1 Yr August (ZAUG)
FFLS23.00-0.09
-0.40%
Future Fund Long/Short ETF (FFLS)